Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Yee

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The Journal of Pathology|July 1, 2016
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinomaDaiana D Becker-Santos, Kelsie L Thu, John C English, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
The New England Journal of Medicine|September 6, 2013
Probability of cancer in pulmonary nodules detected on first screening CTAnnette McWilliams, Martin C Tammemagi, John R Mayo, et al.
Genome Biology|August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitorsSteven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The Journal of Pathology|July 1, 2016
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinomaDaiana D Becker-Santos, Kelsie L Thu, John C English, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
The New England Journal of Medicine|September 6, 2013
Probability of cancer in pulmonary nodules detected on first screening CTAnnette McWilliams, Martin C Tammemagi, John R Mayo, et al.
Genome Biology|August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitorsSteven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 8